Moderna(DE:0QF)
€222.00-6.10 (-2.67%)
DE:0QF
Moderna stock forecast
€222.00
At close:-6.10 (-2.67%)
Moderna (0QF) Stock Forecast & Price Target
38 Followers
0QF Analyst Ratings
Hold
2Buy15Hold3Sell
Based on 20 analysts giving stock ratings to Moderna in the past 3 months
0QF Stock 12 Month Forecast
Average Price Target
EUR 130.36â–¼(-41.28% Downside)Based on 20 Wall Street analysts offering 12 month price targets for Moderna in the last 3 months. The average price target is EUR 130.36 with a high forecast of EUR 273.51 and a low forecast of EUR 40.35. The average price target represents a -41.28% change from the last price of EUR 222.00.
Past 12 Months12 Month ForecastJan2026Oct2026
HighEUR 273.51
AverageEUR 130.36
LowEUR 40.35
Highest Price TargetHighestEUR 273.51Average Price TargetEUR 130.36Lowest Price TargetLowestEUR 40.35
Detailed List of Analyst Forecasts​
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Geoff Meacham | Citi | EUR 71.74 | sell | -67.69%Downside | Reiterated | 11/09/26 | ||
| Edward Tenthoff | Piper Sandler | EUR 206.25→EUR 273.51 | buy | 23.20%Upside | Reiterated | 11/09/26 | ||
| Terence Flynn | Morgan Stanley | EUR 85.19 | hold | -61.63%Downside | Assigned | 11/09/26 | ||
| Michael Yee | UBS | EUR 134.51→EUR 201.77 | hold | -9.11%Downside | Assigned | 11/09/26 | ||
| Salveen Richter | Goldman Sachs | EUR 122.85→EUR 174.86 | hold | -21.23%Downside | Reiterated | 11/08/26 | ||
| Tyler Van Buren | TD Cowen | EUR 80.71→EUR 98.64 | hold | -55.57%Downside | Reiterated | 11/06/26 | ||
| Luca Issi | RBC Capital | EUR 116.58→EUR 130.03 | hold | -41.43%Downside | Reiterated | 11/06/26 | ||
| Alec Stranahan | Bank of America Securities | EUR 197.28→EUR 233.15 | hold | 5.02%Upside | Reiterated | 11/06/26 | ||
| Myles Minter | William Blair | ― | hold | ― | Downgraded | 10/27/26 | ||
| Eliana Merle | Barclays | EUR 112.09 | hold | -49.51%Downside | Reiterated | 10/26/26 | ||
| Cory Kasimov | Evercore ISI | EUR 71.74 | hold | -67.69%Downside | Reiterated | 10/26/26 | ||
| Courtney Breen | Bernstein | EUR 40.35 | hold | -81.82%Downside | Reiterated | 10/25/26 | ||
| Jessica Fye | J.P. Morgan | ― | sell | ― | Reiterated | 09/28/26 | ||
| Andrew Tsai | Jefferies | EUR 53.80→EUR 134.51 | hold | -39.41%Downside | Reiterated | 09/22/26 | ||
| Nico Chen | DBS | EUR 134.51 | hold | -39.41%Downside | Reiterated | 09/11/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Geoff MeachamCiti | SellReiteratedEUR 71.74 | 11/09/26 | -67.69%Downside | ||
| Edward TenthoffPiper Sandler | BuyReiteratedEUR 206.25→EUR 273.51 | 11/09/26 | 23.20%Upside | ||
| Terence FlynnMorgan Stanley | HoldAssignedEUR 85.19 | 11/09/26 | -61.63%Downside | ||
| Michael YeeUBS | HoldAssignedEUR 134.51→EUR 201.77 | 11/09/26 | -9.11%Downside | ||
| Salveen RichterGoldman Sachs | HoldReiteratedEUR 122.85→EUR 174.86 | 11/08/26 | -21.23%Downside | ||
| Tyler Van BurenTD Cowen | HoldReiteratedEUR 80.71→EUR 98.64 | 11/06/26 | -55.57%Downside | ||
| Luca IssiRBC Capital | HoldReiteratedEUR 116.58→EUR 130.03 | 11/06/26 | -41.43%Downside | ||
| Alec StranahanBank of America Securities | HoldReiteratedEUR 197.28→EUR 233.15 | 11/06/26 | 5.02%Upside | ||
| Myles MinterWilliam Blair | HoldDowngraded | 10/27/26 | ― | ||
| Eliana MerleBarclays | HoldReiteratedEUR 112.09 | 10/26/26 | -49.51%Downside | ||
| Cory KasimovEvercore ISI | HoldReiteratedEUR 71.74 | 10/26/26 | -67.69%Downside | ||
| Courtney BreenBernstein | HoldReiteratedEUR 40.35 | 10/25/26 | -81.82%Downside | ||
| Jessica FyeJ.P. Morgan | SellReiterated | 09/28/26 | ― | ||
| Andrew TsaiJefferies | HoldReiteratedEUR 53.80→EUR 134.51 | 09/22/26 | -39.41%Downside | ||
| Nico ChenDBS | HoldReiteratedEUR 134.51 | 09/11/26 | -39.41%Downside |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering Moderna
3 Months
Success Rate29/49 ratings generated profit
59%
Average Return
-10.15%
Copying Mani Foroohar's trades and holding each position for 3 Months would result in 59.18% of your transactions generating a profit, with an average return of -10.15% per trade.
1 Year
Success Rate32/49 ratings generated profit
65%
Average Return
-67.71%
Copying Mani Foroohar's trades and holding each position for 1 Year would result in 65.31% of your transactions generating a profit, with an average return of -67.71% per trade.
2 Years
Success Rate33/49 ratings generated profit
67%
Average Return
-143.86%
Copying Mani Foroohar's trades and holding each position for 2 Years would result in 67.35% of your transactions generating a profit, with an average return of -143.86% per trade.
0QF Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 3 | 5 | 4 | 5 | 2 |
| Hold | 43 | 44 | 31 | 38 | 29 |
| Sell | 11 | 9 | 5 | 4 | 2 |
| Strong Sell | 1 | 1 | 1 | 3 | 4 |
| total | 58 | 59 | 41 | 50 | 37 |
In the current month, 0QF has received 2 Buy Ratings, 29 Hold Ratings, and 6 Sell Ratings. 0QF average Analyst price target in the past 3 months is 130.36.
0QF Financial Forecast
HighEUR -1.36
ConsensusEUR -1.86
LowEUR -2.57
0QF Earnings Forecast
Next quarter’s earnings estimate for 0QF is -EUR 1.86 with a range of -EUR 2.57 to -EUR 1.36. The previous quarter’s EPS was EUR 0.34. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
HighEUR 632M
ConsensusEUR 483M
LowEUR 251M
0QF Sales Forecast
Next quarter’s sales forecast for 0QF is EUR 482.87M with a range of EUR 251.32M to EUR 632.23M. The previous quarter’s sales results were EUR 1.18B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
0QF Stock Forecast FAQ
What is DE:0QF’s average 12-month price target, according to analysts?
Based on analyst ratings, Moderna’s 12-month average price target is €130.36.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Moderna a Buy, Sell or Hold?
Moderna has a consensus rating of Hold, which is based on 2 buy ratings, 15 hold ratings and 3 sell ratings.
What is Moderna’s share price target?
The average share price target for Moderna is €130.36. This is based on 20 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €273.51, and the lowest forecast is €40.35. The average share price target represents a 41.28% decrease from the current price of €222.
What do analysts say about Moderna?
Moderna’s analyst rating consensus is a Hold. This is based on the ratings of 20 Wall Street analysts.
How can I buy shares of Moderna?
To buy shares of DE:0QF, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
